Aortic Aneurysm Market

The Global Aortic Aneurysm Market is estimated to be valued at USD 4.94 Bn in 2025 and is expected to reach USD 11.27 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032. The global aortic aneurysm market represents a critical segment within the cardiovascular medical device industry, addressing one of the most life-threatening vascular conditions affecting millions worldwide.

An aortic aneurysm occurs when the wall of the aorta, the body's largest artery, weakens and bulges outward, creating a potentially fatal condition if left untreated. The market encompasses a comprehensive range of diagnostic tools, surgical devices, endovascular stent grafts, and minimally invasive treatment solutions designed to detect, monitor, and repair these dangerous arterial dilations. With aging populations globally experiencing increased prevalence of cardiovascular diseases, hypertension, and atherosclerosis, the demand for advanced aortic aneurysm management solutions continues to escalate.

The market spans various anatomical locations including thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA), each requiring specialized therapeutic approaches and device technologies.

Innovation in endovascular aneurysm repair (EVAR) techniques, fenestrated and branched stent grafts, and hybrid surgical procedures has revolutionized patient outcomes while reducing procedural risks. Healthcare systems worldwide are increasingly investing in screening programs, advanced imaging technologies, and specialized treatment centers to address the growing burden of aortic aneurysmal disease, driving substantial market growth and technological advancement.

Market Dynamics

The global aortic aneurysm market growth is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The aging global population represents the most significant driver, as advanced age correlates directly with increased aortic aneurysm incidence due to arterial wall degeneration and accumulated cardiovascular risk factors. Rising prevalence of hypertension, diabetes, smoking, and atherosclerotic diseases further amplifies market demand, while technological breakthroughs in endovascular repair techniques, including fenestrated stent grafts and complex branched devices, enhance treatment accessibility and patient outcomes.

Growing awareness among healthcare professionals and patients about screening protocols, coupled with improved diagnostic imaging capabilities such as CT angiography and ultrasound technologies, drives early detection and intervention rates.

However, the market faces notable restraints including the high cost of advanced endovascular devices and surgical procedures, which limit accessibility in developing regions and create reimbursement challenges for healthcare systems. Complex regulatory approval processes for innovative medical devices can delay market entry and increase development costs for manufacturers. Additionally, potential complications associated with endovascular procedures, including endoleaks, device migration, and long-term durability concerns, may restrict adoption rates among conservative practitioners.

Despite these challenges, significant opportunities emerge through expanding healthcare infrastructure in emerging markets, increasing government initiatives for cardiovascular disease prevention, and growing medical tourism sectors. The development of biodegradable stent technologies, artificial intelligence-guided surgical planning, and personalized treatment approaches based on genetic profiling present lucrative avenues for market expansion and innovation.

Key Features of the Study

• This report provides in-depth analysis of the global aortic aneurysm market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aortic aneurysm market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic plc, Cook Medical LLC, W. L. Gore and Associates Inc., Terumo Corporation, Endologix LLC, Cardinal Health Inc., Becton Dickinson and Company (BD), Abbott Laboratories, Boston Scientific Corporation, Braun Melsungen AG, JOTEC GmbH (CryoLife / Artivion), Lombard Medical Technologies, Cordis (a Cardinal Health company / Cordis Inc.), Merit Medical Systems Inc., and LeMaitre Vascular Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aortic aneurysm market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic aneurysm market

Market Segmentation

• Aneurysm Location Insights (Revenue, USD Bn, 2020 - 2032)
• Abdominal Aortic Aneurysm
• Thoracic Aortic Aneurysm
• Thoracoabdominal Aortic Aneurysm
• Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
• Open Surgical Repair
• Endovascular Aneurysm Repair
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• Stent Grafts
• Catheters
• Guidewires
• Balloon Angioplasty Devices
• Other Endovascular Accessories
• Diagnosis Type Insights (Revenue, USD Bn, 2020 - 2032)
• Ultrasound (Screening & Surveillance)
• Computed Tomography Angiography (CTA)
• Magnetic Resonance Angiography (MRA)
• Conventional Catheter Angiography
• Intravascular Ultrasound (IVUS)/Intraoperative Imaging
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
• Below 60 Years
• 60–75 Years
• Above 75 Years
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
• Male
• Female
• End User Insights (Revenue, USD Bn, 2020 - 2032)
• Hospitals
• Specialty Cardiac and Vascular Centers
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Research and Academic Institutes
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
• Online
• Offline
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Medtronic plc
• Cook Medical LLC
• L. Gore and Associates Inc.
• Terumo Corporation
• Endologix LLC
• Cardinal Health Inc.
• Becton Dickinson and Company (BD)
• Abbott Laboratories
• Boston Scientific Corporation
• Braun Melsungen AG
• JOTEC GmbH (CryoLife / Artivion)
• Lombard Medical Technologies
• Cordis (a Cardinal Health company / Cordis Inc.)
• Merit Medical Systems Inc.
• LeMaitre Vascular Inc.

Show more